Evidence map›Paper›PMID 42239030›Full record

ArticleIDCases2026

An imported case of human granulocytic anaplasmosis presenting with altered mental status: A case report.

Shundai Ko, Aki Sakurai, Masakatsu Taira, Harutaka Katano, Ken Maeda, Tadaki Suzuki, Norio Ohmagari

Abstract readCase Reports
In one paragraph

Article in IDCases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shundai KoDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.
Aki SakuraiDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.
Masakatsu TairaDepartment of Veterinary Science, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Harutaka KatanoDepartment of Infectious Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Ken MaedaDepartment of Veterinary Science, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Tadaki SuzukiDepartment of Infectious Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Norio OhmagariDepartment of Infectious Diseases, Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human granulocytic anaplasmosis (HGA) is a tick-borne disease endemic to the northeastern United States but remains extremely rare in Japan. We report an imported case of HGA in a 77-year-old man who had recently traveled from the United States. He presented with a 5-day history of fever, lethargy, and loss of appetite, followed by altered consciousness. Laboratory findings revealed thrombocytopenia, elevated transaminases, and increased creatine kinase levels. Computed tomography was unremarkable except for mild splenomegaly. Considering his recent stay in Bemidji, Minnesota-a region with a high risk of tick exposure-empirical doxycycline therapy was promptly initiated for suspected tick-borne illness. Although indirect immunofluorescence antibody (IFA) assays for IgM and IgG against

Indexed as

Human granulocytic anaplasmosisPCRTick-borne infections

Identifiers

PMID42239030
PMCPMC13226819

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.